News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

M's Science Corporation Initiated European Phase 2 Study in Stroke Recovery



1/30/2008 9:04:22 AM

KOBE, Japan--(BUSINESS WIRE)--M’s Science Corporation (MSC), a clinical stage discovery and development company announced today that it initiated a Phase 2 study in Europe with its lead product SA4503 for treatment of stroke. Earlier this year, MSC announced the initiation of a Phase 2 trial with SA4503 for the treatment of major depression.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES